|
|
Article: Study shows Foradil Aerolizer more effective than slow-release theophylline.(for the treatment of chronic obstructive pulmonary disease)
- Article from:
- Immunotherapy Weekly
- Article date:
- May 8, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Long-term treatment with Foradil Aerolizer (formoterol fumarate inhalation powder) is more effective and better tolerated than treatment with oral slow-release theophylline in patients with symptomatic chronic obstructive pulmonary disease (COPD), according to a new study published in the April 2002 issue of Chest, the official publication of the American College of Chest Physicians.
"One of the most important things we can do for COPD patients is to control their symptoms and improve management of their disease on a daily basis. Since treatment guidelines recommend bronchodilators as the first line of therapy in COPD, ...